Literature DB >> 17318670

Imaging of cholinergic and monoaminergic neurochemical changes in neurodegenerative disorders.

Nicolaas I Bohnen1, Kirk A Frey.   

Abstract

Positron emission tomography (PET) or single photon emission computer tomography (SPECT) imaging provides the means to study neurochemical processes in vivo. These methods have been applied to examine monoaminergic and cholinergic changes in neurodegenerative disorders. These investigations have provided important insights into disorders, such as Alzheimer's disease (AD) and Parkinson's disease (PD). The most intensely studied monoaminergic transmitter is dopamine. The extent of presynaptic nigrostriatal dopaminergic denervation can be quantified in PD and may serve as a diagnostic biomarker. Dopaminergic receptor imaging may help to distinguish idiopathic PD from atypical parkinsonian disorders. Cholinergic denervation has been identified not only in AD but also in PD and more severely in parkinsonian dementia. PET or SPECT can also provide biomarkers to follow progression of disease or evaluate the effects of therapeutic interventions. Cholinergic receptor imaging is expected to play a major role in new drug development for dementing disorders.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17318670     DOI： 10.1007/s11307-007-0083-6

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN： 1536-1632            Impact factor:   3.488


  168 in total

1.  PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.

Authors:  J C STEELE; J C RICHARDSON; J OLSZEWSKI
Journal:  Arch Neurol       Date:  1964-04

2.  Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways.

Authors:  R Hilker; A V Thomas; J C Klein; S Weisenbach; E Kalbe; L Burghaus; A H Jacobs; K Herholz; W D Heiss
Journal:  Neurology       Date:  2005-12-13       Impact factor: 9.910

3.  Visualization of the vesicular acetylcholine transporter in cholinergic nerve terminals and its targeting to a specific population of small synaptic vesicles.

Authors:  E Weihe; J H Tao-Cheng; M K Schäfer; J D Erickson; L E Eiden
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

4.  Evidence that tobacco smoking increases the density of (-)-[3H]nicotine binding sites in human brain.

Authors:  M E Benwell; D J Balfour; J M Anderson
Journal:  J Neurochem       Date:  1988-04       Impact factor: 5.372

5.  Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease: PET evidence of increased dopamine turnover.

Authors:  R de la Fuente-Fernández; J Q Lu; V Sossi; S Jivan; M Schulzer; J E Holden; C S Lee; T J Ruth; D B Calne; A J Stoessl
Journal:  Ann Neurol       Date:  2001-03       Impact factor: 10.422

6.  Imaging of nicotinic and muscarinic receptors in Alzheimer's disease: effect of tacrine treatment.

Authors:  A Nordberg; H Lundqvist; P Hartvig; J Andersson; M Johansson; E Hellstrŏm-Lindahi; B Långström
Journal:  Dement Geriatr Cogn Disord       Date:  1997 Mar-Apr       Impact factor: 2.959

7.  Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment.

Authors:  Steven T DeKosky; Milos D Ikonomovic; Scot D Styren; Laurel Beckett; Stephen Wisniewski; David A Bennett; Elizabeth J Cochran; Jeffrey H Kordower; Elliott J Mufson
Journal:  Ann Neurol       Date:  2002-02       Impact factor: 10.422

8.  Neurological cholinesterases in the normal brain and in Alzheimer's disease: relationship to plaques, tangles, and patterns of selective vulnerability.

Authors:  C I Wright; C Geula; M M Mesulam
Journal:  Ann Neurol       Date:  1993-09       Impact factor: 10.422

9.  Brain acetylcholinesterase after acute parathion poisoning: a comparative quantitative histochemical analysis post mortem.

Authors:  Y Finkelstein; M Wolff; A Biegon
Journal:  Ann Neurol       Date:  1988-08       Impact factor: 10.422

10.  Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's Disease.

Authors:  T Arendt; V Bigl; A Arendt; A Tennstedt
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088
View more
  18 in total

1.  Synthesis and evaluation of in vitro bioactivity for vesicular acetylcholine transporter inhibitors containing two carbonyl groups.

Authors:  Zhude Tu; Wei Wang; Jinquan Cui; Xiang Zhang; Xiaoxia Lu; Jinbin Xu; Stanley M Parsons
Journal:  Bioorg Med Chem       Date:  2012-05-30       Impact factor: 3.641

2.  Heteroaromatic and aniline derivatives of piperidines as potent ligands for vesicular acetylcholine transporter.

Authors:  Junfeng Li; Xiang Zhang; Zhanbin Zhang; Prashanth K Padakanti; Hongjun Jin; Jinquan Cui; Aixiao Li; Dexing Zeng; Nigam P Rath; Hubert Flores; Joel S Perlmutter; Stanley M Parsons; Zhude Tu
Journal:  J Med Chem       Date:  2013-07-18       Impact factor: 7.446

3.  Multimodality imaging characteristics of dementia with Lewy bodies.

Authors:  Kejal Kantarci; Val J Lowe; Bradley F Boeve; Stephen D Weigand; Matthew L Senjem; Scott A Przybelski; Dennis W Dickson; Joseph E Parisi; David S Knopman; Glenn E Smith; Tanis J Ferman; Ronald C Petersen; Clifford R Jack
Journal:  Neurobiol Aging       Date:  2011-10-21       Impact factor: 4.673

4.  The cortical cholinergic system contributes to the top-down control of distraction: Evidence from patients with Parkinson's disease.

Authors:  Kamin Kim; Martijn L T M Müller; Nicolaas I Bohnen; Martin Sarter; Cindy Lustig
Journal:  Neuroimage       Date:  2017-12-19       Impact factor: 6.556

5.  Highlighting the Versatility of the Tracerlab Synthesis Modules. Part 1: Fully Automated Production of [F]Labelled Radiopharmaceuticals using a Tracerlab FX(FN).

Authors:  Xia Shao; Raphaël Hoareau; Brian G Hockley; Louis J M Tluczek; Bradford D Henderson; Henry C Padgett; Peter J H Scott
Journal:  J Labelled Comp Radiopharm       Date:  2011-05-30       Impact factor: 1.921

6.  Altered neural cholinergic receptor systems in cocaine-addicted subjects.

Authors:  Bryon Adinoff; Michael D Devous; Mark J Williams; Susan E Best; Thomas S Harris; Abu Minhajuddin; Tanya Zielinski; Munro Cullum
Journal:  Neuropsychopharmacology       Date:  2010-03-10       Impact factor: 7.853

Review 7.  Radiosyntheses using fluorine-18: the art and science of late stage fluorination.

Authors:  Erin L Cole; Megan N Stewart; Ryan Littich; Raphael Hoareau; Peter J H Scott
Journal:  Curr Top Med Chem       Date:  2014       Impact factor: 3.295

Review 8.  Molecular imaging of neuropsychiatric symptoms in Alzheimer's and Parkinson's disease.

Authors:  Kentaro Hirao; Gregory M Pontone; Gwenn S Smith
Journal:  Neurosci Biobehav Rev       Date:  2014-11-20       Impact factor: 8.989

Review 9.  Where attention falls: Increased risk of falls from the converging impact of cortical cholinergic and midbrain dopamine loss on striatal function.

Authors:  Martin Sarter; Roger L Albin; Aaron Kucinski; Cindy Lustig
Journal:  Exp Neurol       Date:  2014-05-05       Impact factor: 5.330

10.  Four decades of neurodegenerative disease research: how far we have come!

Authors:  Anne B Young
Journal:  J Neurosci       Date:  2009-10-14       Impact factor: 6.167
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.